E-submission
Get new issue alerts
THE KOREAN LIVER CANCER ASSOCIATION
Search
- Page Path
- HOME > Search
Case Report
- Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
- Seong Kyun Na
- J Liver Cancer. 2022;22(2):178-182. Published online June 22, 2022
- DOI: https://doi.org/10.17998/jlc.2022.06.10
- 7,055 Views
- 110 Downloads
- 1 Citation
-
Abstract
PDF - Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying liver disease and is known to be associated with a unique gene mutation. This cancer type is rare in Asia, with only a few cases being reported in Korea. We report a case of FLHCC in a young woman that successfully underwent surgical resection. The efficacy of alternative treatments, such as transarterial chemoembolization or systemic chemotherapies, has not yet been established. To conclude, early diagnosis and appropriate surgical resection are important for the treatment of FLHCC.
-
Citations
Citations to this article as recorded by
- Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal
Mohamed Ismail , Sahiba Singh, Menna-Allah Elaskandrany , David s Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik mahaveer Goyal, Omar Mohamed , Weizheng Wang
Cureus.2024;[Epub] CrossRef
- Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal
First
Prev
Follow JLC on Twitter
